Chris Rock called the government out as drug dealers, and mocks big pharma. The accusation being; big pharma simply makes too much money off of long-term prescription medications that treat symptoms to have any desire for finding a cure.
“Ain’t no money in the cure, the money’s in the medicine… that’s how a drug dealer makes his money—on the come-back.”
More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies, according to research published by a prominent medical journal Tuesday.
Dr. Vinay Prasad, a hematologist-oncologist and assistant professor at Oregon Health and Science University, sought to understand the so-called “revolving door” between the FDA and the pharmaceutical industry, which he said is often discussed but hadn’t been quantified.
“We all know about these anecdotal cases” of a person who was “often a major player at the FDA, someone in an important role — and then they leave the FDA and go and work for industry,” Prasad said, but he couldn’t find anyone who knew whether this happened “5 percent or 60 percent” of the time.